Alere solicits consents under three note series to allow unit's IPO

By Susanna Moon

Chicago, May 21 - Alere Inc. said it began a consent solicitation for its 7¼% senior notes due 2018, its 8 5/8% senior subordinated notes due 2018 and its 6½% senior subordinated notes due 2020.

The company is soliciting consents for waivers and amendments to the note indentures to allow the proposed initial public offering by the company's subsidiary BBI Diagnostics Group plc, according to a company press release.

The proposed waivers and amendments require consents by holders of at least a majority of each series of notes, and they will become operative on the payment date.

The consent solicitation will end at 5 p.m. ET on June 4.

Jefferies LLC is the solicitation agent. Ipreo LLC (888 593-9546 or 212 849-3880) is the information and tabulation agent.

Alere is a Waltham, Mass.-based provider of near-patient diagnosis, monitoring and health management.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.